A 16-year-old boy is referred to you by an epileptologist. He presents with a history of progressive epilepsy that is refractory to medication. The seizures are described as episodes of short bouts of emotionless laughter with loss of awareness that last only a few seconds at a time and occur several times during the day now.
Case 65 Hypothalamic Hamartoma
Abdulrahman J. Sabbagh , Sandeep Mittal , Fahad Eid Alotaibi, and José Luis Montes Clinical Presentation A 16- year-old boy is referred to you by an epileptologist. He presents with a history of progressive epilepsy that is refractory to medication. The seizures are described as episodes of short bouts of emotionless laughter with loss of awareness that last only a few seconds at a time and occur several times during the day now.
He also su ers from generalized tonic-clonic seizures several times a month. Other pertinent  ndings include cognitive delay. He is able to speak. The remainder of his neurologic exam is normal (including motor, sensory, cerebellar, and gait examination). A magnetic resonance imaging (MRI) scan is obtained and shown in Fig. 65 Describe the MRI ( Fig. 65.1 ). MRI shows a small nonenhancing, isointense lesion in the hypothalamic area. The mass occupies the 3 rd ventricle and does not cause hydrocephalus. This is most consistent with a HH. 2. What is the term used for type of seizures this patient is experiencing? Gelastic seizures 3 . How will you work up this patient?
Imaging and electrophysiologic investigations include Electroencephalogram (EEG): can show slow spike and wave EEG patterns with or without multifocal epileptiform abnormalities (typically frontal or temporal) 1 Computed tomography (CT) scan: may show an isodense nonenhancing lesion MRI: shows an isotense to slightly hypointense lesion compared with gray matter 2 Depth electrode recording: When the diagnosis is equivocal and EEG is nonspeci c, specialized centers may consider this modality for diagnosis ( Fig.  65.2 ). 3, 4 Positron emission tomography scan: reveals ictal hypermetabolism at the hamartoma site 5 Single photon emission computerized tomography (SPECT) imaging: measures regional cerebral blood  ow during seizures. Ictal SPECT scans can be done after injection of the tracer technetium-99m hexamethylpropyleneamine oxime (Tc-99m-HMPAO). Magnetoencephalography (MEG): MEG maps interictal magnetic dipole sources onto MRI to produce a magnetic source image 6 Magnetic resonance spectroscopy: decrease in N -acetyl aspartate/creatine and an increase in myoinositol/creatine (mI/Cr) ratios in tumor tissue when compared with values in normal gray matter of the amygdala. Choline/creatine ratios were also increased when compared with those in normal gray matter controls 7 Endocrinologic workup See Case 12, Pituitary Adenoma, for details 4. Brie y describe the anatomy of the hypothalamus; enumerate its nuclei and their functions.
The hypothalamus is commonly subdivided into regions along its anteroposterior axis ( Fig. 65.3 ). 8 The preoptic region extends rostrally to the optic chiasm and dorsally to the anterior commissure. The supraoptic region resides above the optic chiasm.
The tuberal region lies above and includes the tuber cinereum. The mammillary region includes the mammillary bodies and the posterior hypothalamic nuclei. 11 The syndrome is typically characterized by the presence of a HH in association with multisystem malformations.
The spectrum of features also includes pituitary hypoplasia or dysfunction, central postaxial polydactyly, dysplastic nails, bi d epiglottis, and imperforate anus. Additionally, cardiac anomalies, renal defects, and mild mental retardation are seen. PHS is often diagnosed at birth. In familial cases it is inherited in an autosomal dominant pattern with variable expressivity. 
Answers (continued)
Answers (continued) 8 . How do you classify HH? What class does this patients hamartoma belong to? Several classi cation schemes have been described. The most recent and most widely used is the clas-si cation of Delalande and Fohlen (Fig. 65.4 ). 12 The present patients lesion is classi ed as intrahypothalamic (3E) according to Delalande and Fohlens classi cation. 9 . What treatment options can you o er to a patient with HH and intractable seizures? What are their limitations and outcomes? Microsurgical resection: Seizure outcome is related to completeness of resection. 13, 14 Pterional and frontotemporal approach 14 Advantage: shortest, most direct route to the suprasellar cistern and hamartoma Disadvantage: Surgical corridor may be narrowed by the internal carotid artery, optic nerve and tracts, oculomotor nerve, and pituitary stalk. Outcome: 23% of patients are seizure free, 87% have signi cant seizure reduction (in a study of 13 patients). Transcallosal interforniceal approach 15 Advantage: provides a wide exposure to the 3 rd ventricle and an excellent view of the hamartoma from above; avoidance of cranial nerves and blood vessels in the suprasellar cistern and interpeduncular fossa may further reduce the risk of stroke and oculomotor nerve injury Disadvantage: risk of short-term memory de cits because of potential septal, forniceal, or mammillary body injury Outcome: 52% are seizure free, 24% have signicant improvement (in a series of 29 patients ) 15 Complications: thalamic infarct in 7%, increased appetite in 33% (this is permanent in 16%), and short-term memory de cits in 50% Transcallosal, subchoroidal approach: alternative to the transcallosal interforniceal route; lower risk of short-term memory de cits Endoscopic transventricular approach (Fig. 65.5 for an endoscopic view) Outcome: 31% were able to sustain complete resection (14 of 44 patients), of whom 90% were seizure free. 16 Complications: short-term memory di culties (three patients) and hemiparesis (one patient). 16 Disconnection procedure (open or endoscopic) 17 Outcome: 58% seizure free Complications (in a series of 18 patients) 17 : stroke (2 patients), diabetes insipidus (2 patients), meningitis (1 patient) Stereotactic radiosurgery 18 Gamma knife radiosurgery: good treatment for small-and medium-size hamartomas. The median dose recommended at the marginal isodose is 17 Gy (range is 1326 Gy). Outcome: 37% seizure free. Most had cognitive and behavioral improvement. Complications: 15% transient worsening of seizures; no permanent complications mentioned. Linear acceleration-based radiosurgery Stereotactic brachytherapy Stereotactic radiofrequency ablation Outcome: 25% seizure free, 25% signi cant improvement (12 patients ) 19 Complications: 8% mortality (1 patient), 16% memory de cits Vagal nerve stimulation: limited role; palliative and seizure freedom is not expected. 20 Corpus callosotomy: limited role
